Characterization of White Blood Cells Sub-populations From Multiple Sclerosis Patients.

• Conditions: Multiple Sclerosis

• Registration Number: NCT03486665
• Lead Sponsor: Bioimmunate

Brief Summary

Multiple sclerosis (MS) is a chronic progressive neurological autoimmune disease, that gradually affects patient's quality of life. There are about 2.5 millions patients world wide, with an increasing cost Burdon. Up to date, it remains unclear who are the exact cells to initiate the disease. During the disease, the repertoire of cells expands and undergoes changes. The purpose of this study is to characterize those changes.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2018-03-21
• Study First Submitted QC: 2018-04-01
• Study First Posted: 2018-04-03
• Study Start: 2018-04-24
• Status Verified: 2018-07
• Last Update Submitted: 2018-07-18
• Last Update Posted: 2018-07-19
• Primary Completion: 2018-09
• Study Completion: 2020-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Patients with diagnosis of MS according to the revised criteria of McDonald or healthy volunteers
• Ability to provide written informed consent.

Exclusion Criteria

• Active malignant disease

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quantification of disease related white blood cells from blood and/ or CSF	through study completion, an average of 6 months

Trial Locations

Locations (1)

Hadassah Medical Center; 🇮🇱 Jerusalem, Israel